Sponsored by: Imprivata
n 2010, the Federal Drug Enforcement Administration (DEA) published an interim final rule as to what vendors and healthcare organizations need to do to support Electronic Prescribing of Controlled Substances. Since that time many vendors have updated their solutions to meet these requirements and EPCS is slowly gaining adoption. This whitepaper simplifies the DEA ruling and identifies how to focus your planning to have a successful DEA compliant EPCS roll-out. Fill out the form below to learn more.
Please enter your email address to access this resource